DUK vs OCUL · P/E 19, rev $31.74B vs rev $24.3M
Duke Energy Corporation (DUK) versus Ocular Therapeutix Inc (OCUL) — a side-by-side from cached financials, not a winner call.
Duke Energy Corporation (DUK) is a utilities - regulated electric company listed on NYSE.
Ocular Therapeutix Inc (OCUL) is a biotechnology company listed on US.
Latest reported DUK revenue for 2025-12-31 was $31.74B. Net income was $4.97B. Revenue was up 5.6% from 2024-12-31 to 2025-12-31. DUK currently screens at market cap $96.46B and trailing P/E 19.0.
Latest reported OCUL revenue for 2026-06-30 was $24.3M. Net income was -$167.4M. OCUL currently screens at market cap $1.76B.
DUK currently screens at market cap $96.46B and trailing P/E 19.0. OCUL currently screens at market cap $1.76B.
Not investment advice. Open the DUK and OCUL stock pages for the full models.
Not investment advice.